Goldenwell Biotech, Inc. (GWLL) stock
GWLLOTCFood and Kindred ProductsFiscal year ends December 31
$0.65+0.05 (+8.33%)
Close on Oct 19, 2026Market cap $64.35MP/E –Yield –
Goldenwell Biotech operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Goldenwell Biotech's operating cash flow for the twelve months ending Jun 30, 2026 was -$110.37K. For fiscal 2025 it was -$22.63K. The highest annual figure on record is -$2.31K in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$22.63K | – |
| FY2024 | Dec 31, 2024 | -$123.08K | – |
| FY2023 | Dec 31, 2023 | -$113.15K | – |
| FY2022 | Dec 31, 2022 | -$1.07M | – |
| FY2021 | Dec 31, 2021 | -$205.14K | – |
| FY2020 | Dec 31, 2020 | -$6.32K | – |
| FY2019 | Dec 31, 2019 | -$2.31K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$47.27K | -179.6% |
| Q1 FY2026 | Mar 31, 2026 | -$13.36K | – |
| Q4 FY2025 | Dec 31, 2025 | -$18.85K | – |
| Q3 FY2025 | Sep 30, 2025 | -$30.89K | – |
| Q2 FY2025 | Jun 30, 2025 | $59.38K | – |
| Q1 FY2025 | Mar 31, 2025 | -$32.28K | – |
| Q4 FY2024 | Dec 31, 2024 | -$25.35K | – |
| Q3 FY2024 | Sep 30, 2024 | -$20.97K | – |
| Q2 FY2024 | Jun 30, 2024 | -$47.75K | – |
| Q1 FY2024 | Mar 31, 2024 | -$29.01K | – |
| Q4 FY2023 | Dec 31, 2023 | -$19.08K | – |
| Q3 FY2023 | Sep 30, 2023 | -$35.21K | -331.3% |
| Q2 FY2023 | Jun 30, 2023 | -$26.95K | – |
| Q1 FY2023 | Mar 31, 2023 | -$31.92K | – |
| Q4 FY2022 | Dec 31, 2022 | -$917.09K | – |
| Q3 FY2022 | Sep 30, 2022 | $15.22K | – |
| Q2 FY2022 | Jun 30, 2022 | -$25.04K | – |
| Q1 FY2022 | Mar 31, 2022 | -$145.66K | – |
| Q4 FY2021 | Dec 31, 2021 | -$19.37K | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.51K | – |
| Q2 FY2021 | Jun 30, 2021 | -$150.20K | – |
| Q1 FY2021 | Mar 31, 2021 | -$150.20K | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.98K | – |
| Q3 FY2020 | Sep 30, 2020 | -$878 | – |
| Q2 FY2020 | Jun 30, 2020 | -$142 | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.33K | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.31K | – |
See a number that looks wrong?